QEYOMY
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Apr 2024)
What this means for you
This application is over — abandoned 22 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90262916
- Mark type
- Stylized text
- Filed
- 19 Oct 2020
- Published for opposition
- 25 Jul 2023
- Abandoned
- 22 Apr 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer and skeletal abnormalities
- Class 042 — Scientific and technological services: Conducting research and development in the fields of cancer and skeletal abnormalities
Owner
- QED Therapeutics, Inc., Brisbane, CA, US
- QED Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 22 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 13 May 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 20 Sept 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 20 Mar 2021 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 20 Mar 2021 — LETTER OF SUSPENSION E-MAILED
- 20 Mar 2021 — SUSPENSION LETTER WRITTEN
- 18 Mar 2021 — ASSIGNED TO EXAMINER
- 06 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED